Trilitas Gel
Product Images NDC 87143-200

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Trilitas (NDC 87143-200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Perfero Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Trilitas 01)

Chemical structure of Tazarotene, showing its molecular framework with rings and side chains including sulfur and ester functional groups.*

FDA Label Image

Principal Display Panel (Trilitas 02)

Packaging label for Trilitas (tazarotene) gel 0.1%, 30 grams, topical dermatologic gel by Perfero Pharma, Inc. The label includes product name, active ingredient strength, NDC 87143-200-30, storage instructions, distributor information, and usage guidance. It prominently states 'For Dermatologic Use Only. Not for Ophthalmic Use.' and 'Rx Only.'*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.